In the initial experiments reviewed here, we show that atrial natriuretic peptide (ANP) plays an important inhibitory role in the control of sodium chloride and water intake since injections of ANP into the third ventricle (3V) caused a reduction in dehydration-induced drinking and also the drinking of salt in salt-depleted rats. Attention was then turned to the possible role of the brain ANP neurons in producing natriuresis which had earlier been shown to be caused by stimulations within the anterior ventral third ventricular region (AV3V). Stimulation in this region by carbachol produced natriuresis accompanied by a dramatic increase in plasma ANP concentrations and increased content of the peptide in medial basal hypothalamus (MBH), neurohypophysis (NH) and anterior pituitary gland (AP), without alterations in the content of ANP in lungs or atria. This suggested that the natriuresis resulting from the stimulation is brought about, at least in part, by the release of ANP from the brain. Conversely, there was a dramatic decline in plasma ANP at both 24 and 128 h after AV3V lesions had been placed. In view of the much larger quantities of the peptide stored in the atria, it is probable that the changes in the atrial release of the peptide were the main factors altering plasma ANP, but that there was concomitant alteration in the release of brain ANP as well. Blood volume expansion (BVE) by intraatrial injection of isotonic saline in the rat is a profound stimulus for ANP release. Lesions in the AV3V region, median eminence, or neurohypophysectomy blocked BVE-induced release of ANP indicating the crucial participation of the CNS in the response of ANP and natriuresis. Baroreceptor impulses from the carotid-aortic sinus regions and the kidney are important in the neuroendocrine control of ANP release since deafferentation of these regions lowered basal plasma ANP concentrations and prevented the increase after BVE. The evidence indicates that the ANP release, in response to BVE, is mediated by afferent baroreceptor impulses to the AV3V, which mediates the increased ANP release via activation of the hypothalamic ANP neuronal system. Our recent data support the hypothesis that BVE causes the release of ANP from ANPergic neurons in the hypothalamus that in turn stimulates release of oxytocin from the neurohypophysis. This oxytocin acts to release ANP from the right atrium that has negative chrono-and inotropic effects in the right atrium to reduce cardiac output, thereby reducing effective circulating blood volume. Then, the released ANP circulates to the kidneys and evokes natriuresis to return circulating blood volume to normal. This is further accomplished by reduction in intake of water and salt mediated also by brain ANP.
Introduction

1964) to do my postdoctoral studies under Professor
McCann's supervision.
With Dr Covian, we started to investigate the role saline. 8 Our group in Brazil, and McCann with Orias and Mariana Morris in the USA, carried out indeplayed by the CNS in the control of salt intake. 5 In our laboratories, systematic studies were undertaken to pendent studies to investigate the effects of cholinergic, adrenergic and hypertonic saline injections determine the effects of bilateral localized lesions of the rat hypothalamus on the free choice ingestion of into the 3V of conscious male rats made diuretic by intragastic water load. Both natriuretic and kaliuretic tap water and 2% NaCl solution. After several experiments were performed, it was possible to demonstrate responses and an increase in the Na + /K + ratio were induced by intraventricular injection of noradrenalin the existence of a neural circuit that controls the sodium intake and/or excretion. This circuit seems to and carbachol, whereas dopamine had no effect. The beta receptor stimulator, isoproterenol, induced an involve the septal area and particularly the AV3V, amygdaloid complex and hypothalamus. The role antinatriuretic and antikaliuretic effect. To determine the nature of the receptors involved, we injected adreplayed by the circuit in sodium intake was demonstrated by electrolytic lesions and by electrical and nergic blockers and found that the alpha adrenergic blocker, phentolamine, abolished the natriuretic chemical stimulation. Lesions of the anterior medial hypothalamus caused a decrease in the intake of saline response to intraventricular injection of either hypertonic saline, noradrenaline or carbachol. In contrast, solution, while lesions in the anterior lateral hypothalamus caused an increase in saline intake. Lesions the beta adrenergic blocker, propranolol, induced a natriuresis and kaliuresis when injected alone. Proof the septal area also increased salt intake. Lesions of the corticomedial region of the amygdala increased Na + pranolol also potentiated the natriuretic response to carbachol. Cholinergic blockade with atropine diminintake and lesions of the basolateral region decreased it. When the same sites of the septum and amygdala ished the response to norepinephrine and blocked the natriuretic response to hypertonic saline. 9 At that time that had altered Na + intake were stimulated electrically, stimulation of the septal area was specific for with McCann, we suggested that sodium receptors in the ventricular wall modify renal sodium excretion by intake of this ion. Interaction studies provided evidence that the hypothalamus is the principal structure a stimulatory pathway involving cholinergic and alpha adrenergic receptors and that it can inhibit sodium in the circuit regulating saline ingestion/excretion and that the septum and amygdala have modulating influexcretion by a tonically active beta receptor pathway. Much later, these receptors were described by Petrovic ences on its activity in this regard. 6 To study the synaptic transmitters involved in these et al. 10 Our group in Ribeirao Preto (Brazil) mapped the varieffects, carbachol, noradrenaline and hypertonic saline solution (NaCl 2%) were microinjected into the septal ous pathways within the CNS controlling salt intake and excretion. Cholinergic and adrenergic stimulation area or AV3V regions. They did not increase salt intake, as occurs with the application of ANG-II; howof the medial septal area, medial preoptic area, anterior lateral hypothalamus, subfornical organ as well as the ever, cholinergic and alpha-adrenergic pathways appear to be involved in the natriuretic and kaliuretic AV3V region induced a dose-related natriuresis accompanied by a lesser kaliuresis. Thus, considerable effects obtained by microinjection of these neurotransmitters into the septal, AV3V or 3rd ventricle evidence indicates that the medial preoptic area, anterior, lateral hypothalamus, subfornical organ, areas. Therefore, it was clear to us at that time that structures controlling the intake of sodium were also AV3V, habenula, stria medullaris, supraoptic nucleus, medial septal area and paraventricular nucleus are implicated in the control of its urinary output.
On the basis of McCann's work on neural control of organized in a neural circuit involved in the regulation of water and sodium intake.
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body fluids, I joined him in Philadelphia in 1964. We evaluated the effect of various transmitters on water, The role played by the CNS in the control of renal sodium excretion has also been demonstrated by sevsodium chloride and food intake and reported that the intraventricular (ICV) injection of carbachol induced a eral other laboratories. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] At this time, we were looking for the mechanism dramatic, rapid increase in water intake with no changes in food intake. This was in agreement with which coulld explain the observed effects from central nervous system manipulation. The median eminence earlier findings of SP Grossman who injected these drugs into hypothalamic tissue. 7 Both carbachol and lesions temporarily blocked the natriuresis, kaliuresis and antidiuresis which followed the injection of hyperisoproterenol, a beta adrenergic agonist, evoked large increases in salt intake. Hypertonic saline injected into tonic saline, carbachol or noradrenaline into the 3V. Sham lesions did not interfere with the responses. the 3V produced a delayed increase in both water and food intake, but did not alter sodium intake. We interHypophysectomy did not block but delayed the responses which ruled out the participation of anterior preted the results to mean that there was a cholinergic synapse in the pathways, which mediate water intake, pituitary hormones. 21 The responses still occurred in rats with diabetes insipidus which lacked AVP. 22 whereas both cholinergic and adrenergic synapses might be involved in the mediation of salt and food During the sixties, much attention was paid to the possibility of the existence of a natriuretic hormone. intake.
With Dorn, we showed that intraventricular injection Cort and his coworkers 23 even reported the purification of a hypothalamic natriuretic factor. At this time, Orias of carbachol evoked a natriuretic response which mimicked the response to intraventricular hypertonic and McCann started working on the problem and were able to demonstrate that AVP, OT and ␣-MSH had of ANP did not block responses to larger doses of ANGII ranging from 96 to 956 pmol. 35 Similar results natriuretic activities in water-loaded rats.
24-26 Until now, it was not clear that these hormones had a physiowere described by Massoto and Negro-Vilar 36 and Inagami's groups. 37 logical role in the induction of natriuresis. Orias and McCann obtained natriuretic activity in median emiSince ANGII also increases salt intake, we speculated that ANP should have the opposite effect and would nence extracts and, at this time, they thought that they had ruled out the possible participation of AVP and inhibit saline intake when injected into the 3V of conscious, salt-depleted rats. The animals were salt-OT in this activity since the treatment of the extracts with thioglycollate, an agent which opens the disulfide depleted by 4 days of salt restriction followed by intraperitoneal dialysis with 5% glucose solution to probridge in the neurophyophyseal hormones, thereby inactivating them, did not interfere with the natriurduce hyponatria. Intake of 1.5% sodium chloride solution was reduced dramatically by a minimal effective etic activity.
De Wardener and Clarkson 27 presented evidence dose of 0.2 nmol of ANP. 38 showing that natriuresis could occur following blood volume expansion, even though factors such as Brain ANPergic neuronal system and release of increased glomerular filtration rate, or changes in aldo-ANP sterone secretion were eliminated. Davis and Freeman obtained evidence for a circulating natriuretic factor in We next addressed the question of the possible role of the brain ANPergic neuronal system in CNS-induced volume-expanded dogs by cross-circulation experiments. 28 Gauer and Henry 29 showed that dilation of the natriuresis brought on by intraventricular injection of hypertonic saline or activation of brain cholinergic and atria could induce diuresis. At that time, it was thought that distension of the atria activated impulses which adrenergic circuits by carbachol or norepinephrine. In the early days, we thought that these effects were traveled up the vagus to inhibit the release of AVP. Immersion in thermal baths had been known to evoke brought about by the release of a hypothalamic natriuretic hormone. Alternatively, they might be brought diuresis since the mid-19th century. Immersion probably increased venous return to the heart and dilated about by neural activation of the release of ANP from the atria. Therefore, we evaluated the possible role of the atria.
Therefore, it was very important to know if the brain ANP in evolving the changes in renal sodium excretion that followed stimulations or lesions of the diuresis and natriuresis which follows the distension of the atria was not due to a reflex activation of the AV3V, a region previously implicated in control of sodium excretion by earlier experiments.
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brain but instead to the release of atrial natriuretic peptide (ANP), discovered by De Bold's group, 30 which cirInjection of carbachol into the AV3V produced natriuresis as expected on the basis of our earlier expericulated to the kidneys and evoked natriuresis.
ments, which was accompanied by a dramatic increase in the plasma ANP concentration and an increase in The brain ANPergic neurons ANP content in the medial basal hypothalamus (MBH), the neurophypophysis (NH) and particularly in the In 1985, Samson demonstrated the presence of ANP in extracts from various hypothalamic regions. 31 Philanterior pituitary gland (AP), but without alterations in the content of ANP in the lungs or the right or left lips 32 reviewed the immunocytochemical studies demonstrating that the ANP neurons were located in the atrium. 39 Conversely, there was a dramatic decline in plasma same regions of the CNS which are related to ANG-II and blood pressure regulation. These findings gave us ANP at both 24 and 120 h after the AV3V lesions had been placed. This was accompanied by a slight decline the idea that ANP could be also involved in control of water intake. The ANPergic neurons are localized in in the content of the peptide in the lungs. There were no changes in its content in the right atrium at 24 h the region extending from the paraventricular nucleus rostrally to the organum subfornicalis and ventrally to after lesions, but there was a significant increase in 120 h. There was a dramatic decline in the ANP conthe organum vasculosum lamina terminalis, areas known to be involved in thirst, and their axons also tent in the MBH, NH, AP, choroid plexus and olfactory bulbs (OB). These reductions persisted or became more project caudally and ventrally to the median eminence and neural lobe, terminating in proximity to the long evident at 120 h, except in the olfactory bulb in which the decline was no longer significant. 40 or short portal vessels, so that the peptide could be released into the anterior pituitary (AP) sinusoids and Since the dramatic increase in plasma ANP after carbachol stimulation of the AV3V was accompanied by also into the general circulation. 33, 34 marked elevation in content of the peptide in the basal hypothalamus and the neuro-and adenohypophysis, The ANPergic neurons in water and salt intake we suggested that the natriuresis resulting from this stimulation is brought about, at least in part, by the With McCann, we demonstrated that ANP induces a dose-related blockade of dehydration and ANGIIrelease of ANP from the brain. Along the same line of reasoning, the decline of ANP induced drinking. 35 This inhibitory response was present at doses of intraventricularly injected ANGII in the plasma and in these same tissues (MBH, OB, choroid plexus, NH and AP) which was accompanied ranging from 4.8 to 25 pmol; however, the 2-nmol dose by a decrease in sodium excretion in rats with AV3V 100 g body weight, over 1 min) in conscious freely moving rats. In sham-operated rats, the BVE induced a lesions, may be explained at least in part by decreased release of ANP from the brain. In view of the much rapid increase in plasma ANP as before. The concentration peaked at 5 min and remained elevated at larger quantities of the peptide stored in the atria, it is probable that changes in atrial release contribute in a 15 min after saline injection. One week after deafferentation of the carotid-aortic baroreceptors, basal major way to the alterations in plasma ANP observed after the stimulation or ablation of the AV3V region.
plasma ANP concentrations were highly significantly decreased on comparison with values of sham-operHowever, these results suggest that the dramatic changes in plasma ANP that followed these manipuated rats. Plasma ANP levels, at 5 min after BVE in the deafferented rats, were greatly reduced. Unilateral right lations may be due to altered release of the peptide from the brain structures as well as the atria and vagotomy reduced resting levels of plasma ANP, but not the response to BVE. The resting levels and BVE lungs. 40 response were normal in bilateral vagotomized rats. In the rats that had undergone renal deafferentation, the Role of the ANPergic neurons in volume resting levels were normal, but the response to BVE expansion-induced release of ANP was significantly reduced. These data indicated that the afferents impulses via right vagus nerve may be It was well known at this time that expansion of the blood volume (BVE) causes a release of ANP that is important under basal conditions, but they are not required for the ANP release induced by BVE. In conbelieved to be important in induction of the subsequent natriuresis and diuresis which, in turn, acts to reduce trast, baroreceptor impulses from the carotid-aortic sinus regions and the kidney are important pathways the increase in blood volume. Since stimulation of the AV3V region induced a rapid elevation of plasma ANP, involved in the neuroendocrine control of ANP release. The evidence from these experiments and our previous whereas lesions of the AV3V are followed by a marked decrease in plasma concentration of the peptide, we stimulation and lesion studies indicates that the ANP release in response to volume expansion is mediated hypothesized that release of ANP from the brain ANP neuronal system might be important to the control of by afferent baroreceptor impulse input to the AV3V region, which mediates the increased ANP release via plasma ANP. To test this hypothesis, we destroyed the AV3V, the site of the perikarya, in male rats by electroactivation of the hypothalamic ANP neuronal system. 42 In another group of experiments, we determined the lytic lesions as just described. Other lesions were made in the median eminence and posterior pituitary sites necessity of the brain ANP neuronal system for BVE ANP release induced by hypertonic or isotonic saline, of termination of the axons of these neurons, and also hypophysectomy was performed in other animals. 41 by injecting an antiserum directed against ANP into the 3rd ventricle prior to inducing BVE. The antiserum had In conscious, freely moving rats, volume expansion and stimulation of postulated sodium receptors in the no effect on resting levels of ANP; however, it partially blocked the increase in ANP and natriuresis which folhypothalamus were induced by intra-atrial injection of hypertonic saline (NaCl 0.3 M; 2 ml per 100 g body lowed the BVE. 43 Other experiments in sheep had given similar results. 44 weight, over 1 min). Volume expansion was also induced with the same volume of isotonic saline or Finally, we evaluated the essentiality of cholinergic and adrenergic synapses within the brain on the glucose 5%. In the sham-operated rats, BVE with hypertonic or isotonic solution induced equivalent response of ANP to BVE by injecting the receptorblocking agents into the 3rd ventricle 30 min before the rapid increases in plasma ANP that peaked at 5 min and returned to control values by 15 min. These lesions BVE. These blockers had no effect on resting levels of hormone; however, a highly significant blockade of the (AV3V, ME, NH, or Hypox) caused a decrease in the basal levels of plasma ANP in comparison with those response was induced by prior injection of the muscarinic cholinergic receptor blocker, atropine sulfate of the sham-operated rats. Each type of lesion induced a highly significant decrease of the response to BVE on (5 nmol in 2 l 0.9% NaCl). Similar results were obtained with micro-injection of the alpha receptor testing 1 or 5 days after lesions were made. Because a common denominator of the lesion was the elimination blocker, phentolamine (5 nmol in 2 l saline). 45 We have illustrated the putative pathway of actiof the brain ANP neuronal system, these results suggest that the brain ANP plays a role in the mediation of the vation of ANP release and natriuresis via BVE (Figure 1 ). It involves distension of baroreceptors in the release of ANP that occurs after volume expansion.
Thus, the results at this point indicated the crucial right atria, carotid and aortic sinuses and in the kidney which alters their afferent input to the brain stem in the participation of the CNS in the response of ANP and natriuresis to volume expansion. We considered the nucleus tractus solitarius (NTS). Impulses from there activate the locus coeruleus (LC), since lesions of the possibility that the baroreceptors, when they were stretched by BVE, would activate the brain ANP neu-LC, a major source of noradrenergic axons to the hypothalamus lowered resting ANP levels (J Anselmorons which would then produce the release of ANP and the ensuing natriuresis. We set out to determine the Franci and J Antunes-Rodrigues, unpublished). The axons of these noradrenergic neurons projecting to the role of baroreceptors in affecting the increase in plasma ANP from the BVE induced by i.v. (intra-atrial) injec-AV3V region activate the cholinergic interneurons there, which in turn, stimulate the hypothalamic tion of hypertonic saline solution (0.3 M NaCl, 2 ml per released from the brain plays a minor role in the response. Rather, we would suggest that these ANPergic neurons activate descending pathways which then activate efferent pathways to the heart with consequent release of ANP from the cardiac myocytes. The efferent pathway to the heart might be completely neural; however, it cannot be cholinergic since bilateral section of both vagi does not block the response to BVE. It is unlikely that it is a sympathetic efferent pathway, since BVE by elevating blood pressure should, if anything, diminish sympathetic outflow. Rather, we suspect that ANP may be released by an unknown efferent pathway reaching the atria. It could be peptidergic in nature. Alternatively, ANP neurons may stimulate release of other brain peptides from the neurohypophysis such as endothelin, 46 AVP or OT. 47 AVP and particularly OT are natriuretic peptides and can be released in large quantities from the neurohypophysis. Therefore, we considered the possibility that they might be released by BVE, circulate to the right atrium and directly release ANP. As indicated above, the axons of ANP neurons terminate in the neurohypophysis and these could contribute to the ANP release from BVE. However, as stated before, these neurons are unlikely to provide enough ANP to account for the BVE-induced release since their ANP content is 1000 times less than that of the right atrium. Decreases in blood volume, such as occur with hemorrhage, stimulate vasopressin release via baroreceptor input to the brain stem. Therefore, one would predict that BVE would not elevate, and perhaps would suppress, vasopressin release. Therefore, we hypothesized that hypothalamic ANP neurons cause release of oxytocin which triggers the release of ANP from the atria. We found that BVE induced concurrent oxytocin and ANP release which was followed by natriuresis. Isotonic BVE decreased plasma vasopressin concen- 
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In water-loaded rats undergoing diuresis, oxytocin induced a significant (PϽ0.01), dose-related increase in sodium and potassium excretion, as well as in urine ANPergic neurons. These neurons would activate efferent neurohumoral or neuronal pathways which induce osmolality. A dose-response relationship was evident by 20 min with sodium and by 40 min with potassium. the release of ANP from the brain and the atria. What are the efferent pathways involved in the brain control
The natriuresis was maximal at 40 min. The kaliuretic response was smaller than that of sodium. There was of ANP release? Some of the ANP neurons terminate in the median eminence and neural lobe of the also a dose-related decrease in urine volume which was maximal at 40 min with the 1-nmol (1.0 g) dose hypophysis. It is probable that their activation leads to release of the peptide into the vasculature draining the and at 80 min for the 10-nmol dose. Control injections of isotonic saline did not induce any significant median eminence or the neural lobe. [39] [40] [41] Since the quantity of the peptides is 1000-fold less in these strucchanges in the values for urine volume, sodium and potassium excretion and urine osmolality. tures than in the atria, [39] [40] [41] we believe that ANP
Effect of oxytocin on plasma ANP
effect of Atripeptin II on force and rate of contractions of isolated, spontaneously beating rat atria in vitro in In water-loaded rats, plasma ANP concentrations concentrations of up to 4 × 10 −8 M. They also described increased significantly (PϽ0.01) and maximally at that at this concentration, ANP produced a maximal 20 min after i.p. injection of OT (10 nmol) which relaxation in the aorta and carotid artery. Presumably, induced the greatest natriuretic response. In the salinethey would have found effects with the higher conceninjected controls, there were no significant changes in trations used in our experiments. Oxytocin had a simiplasma ANP. In rats which were not water-loaded, i.v. lar negative ino-and chronotropic effect on the atria at injection of OT induced a dose-related increase a slightly higher dose and its effects were slightly (PϽ0.001) in plasma ANP concentrations at 5 min after reduced in atropinized atria to eliminate any effects of i.v. injection. The minimal effective dose was 1 nmol. acetyl choline. Thus, OT by releasing ANP, may act as The plasma ANP levels remained elevated for 15 min a cardiac muscle relaxant and exert a negative chronoonly with the highest dose (10 nmol) of OT. No changes tropic action as well. in plasma ANP levels were observed in the control rats.
We thought that these effects of OT were mediated by the ANP released by this polypeptide, but the concentrations of ANP in this relatively large tissue bath Effect of BVE on plasma oxytocin concentrations (25 ml) precluded measurement of ANP by RIA. Conse-BVE is a well-known stimulus for ANP release. In this quently, in another set of experiments, we incubated experiment, we wished to determine the effect of BVE quartered atria singly in 1 ml of incubation medium. on release of OT, the putative stimulator of ANP OT (10 −6 M) stimulated ANP release (PϽ0.01). This release. BVE either with isotonic or hypertonic saline action was blocked by an OT antagonist (Ferring, induced a rapid increase in plasma OT concentration Malmo, Sweden), which by itself at 10 −6 or 10 −9 M also that was highly significant at 5 min. Although the lowered basal release of ANP significantly. These release of OT was greater with the hypertonic saline results indicate that in this in vitro preparation, OT is solution, it was not significantly greater than that acting physiologically to stimulate ANP release.
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caused by isotonic saline. By 15 min, OT levels Thus we have demonstrated direct actions of OT on returned to the basal levels in the case of isotonic atrial functions, presumably mediated by ANP since saline, but were still significantly elevated after hypersimilar effects were obtained by 8-monobutyry-cGMP, tonic saline-induced BVE. Isotonic or hypertonic an analog of cGMP which mimics the actions of cGMP. saline-induced BVE was associated with equivalent Therefore, we believe that OT has a physiologically sigincreases in plasma ANP with a similar time-course as nificant effect to release ANP in vivo and in vitro. The that found for plasma OT concentrations observed in released ANP has a negative ino-and chronotropic this experiment.
effect in the heart and also dilates blood vessels to proThe magnitude of the release of OT following BVE duce a rapid decrease in effective circulatory blood was even greater than that which followed suckling in volume following blood volume expansion. This is follactating rats, the classical stimulus for OT release. The lowed by natriuresis induced by the renal action of OT release induced by suckling also was associated ANP, returning blood volume to normal. with an increase in plasma ANP and this increase was prevented by prior injection of an OT antagonist which Effect of i.v. injection of AVP on plasma ANP supports the hypothesis that the ANP-releasing action of OT is physiologically significant. 47 In rats which were not water-loaded, there was an increase (PϽ0.001) in plasma ANP concentrations at 5 min after i.v. injection of AVP (100 ng per rat). No Direct effect of OT in the atria to release ANP and changes in plasma ANP levels were observed in the to alter cardiac functions control rats. There was also an increase (PϽ0.03) in plasma ANP concentrations at 5 min after i.v. injection Since our in vivo experiments indicated that OT stimulated ANP release from the heart, experiments were of the V2 agonist dDAVP (50 ng per rat). Values were no longer significantly elevated at 15 min. Thus, by V2 undertaken to investigate possible direct effects of OT on the atria. Besides the well-known OT effects on receptors, AVP can also stimulate ANP release. It does not mediate isotonic BVE-induced ANP release since uterus and mammary gland, it was also described that OT increased blood pressure in vivo. We hypothesized plasma AVP levels decline, but could be involved in hypertonic BVE since AVP concentrations rise. 47 that OT might release ANP which would decrease atrial function, thus rapidly reducing effective circulating blood volume. In a series of experiments, right atria Lack of role renal nerves in natriuresis evoked by were mounted in a tissue bath, and the effects of OT hypothalamic stimulation to modify the force or rate of spontaneously beating right atria was examined by cumulative addition. At a It is well known that electrical stimulation of parts of the CNS, lesions of the hypothalamus (AV3V) and concentration of 3 × 10 −7 to 10 −5 M, a decrease in the force and rate of atrial contraction was observed with injection or infusion of certain neurotransmitters, certain drugs or hypertonic solutions into discrete areas ANP. 48 The results are not in agreement with those described by Cohen and Schenck 49 who tested the of the CNS produce natriuresis in several mammalian species. Our group and that of McCann found that injection of the cholinergic agent (carbamylcholine (carbachol)), adrenergic (norepinephrine) or hypertonic saline solution (NaCl 2%), into the AV3V of rats causes a reproducible natriuresis. Silva-Netto et al 18 studied the effect of carbachol stimulation of the lateral hypothalamic area (LHA) in rats with innervated or denervated kidneys. As expected, the control diuresis and natriuresis was significantly higher from the denervated kidneys, indicating 'denervation diuresis'. Carbachol stimulation led to a highly significant increase in urine volume and sodium excretion from both the innervated or denervated kidneys. Therefore, the natriuresis induced by cholinergic stimulation of the LHA does not require presence of the renal nerves and is presumably mediated hormonally as already described.
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Other clearance and micropuncture studies were performed by Silva-Neto et al 17 before and after hypothalamic injection of carbachol. Some of these rats received pharmacological doses of AVP and mineralocorticoids (DOCA) throughout the experiment to eliminate their effect on the results. Glomerular filtration rate and renal plasma flow increased by 33% and 50% respectively following injection of carbachol. Fractional excretion of sodium increased significantly from 0.2% to 0.26%. Similar effects were obtained in rats given pharmacological doses of AVP and DOCA throughout the experiments. Injection of carbachol resulted in a significant inhibition of sodium reabsorption in both proximal and distal tubules and this effect persisted for at least 90 min.
Other experiments were performed in rats with abdominal aorta constriction above the kidneys, so as to maintain renal perfusion pressure constant and slightly lower than systemic arterial blood pressure. In spite of these adverse circumstances, urine volume and coincided with a fall in blood pressure (during the first 6 and 9 min). Subsequently, blood pressure increased significantly. This increase in blood pressure may account for the depressed renal nerve activity observed baroreceptor input to the brain stem in the nucleus tractus solitarius (NTS) (Figure 2 ). These neurons send from 9 to 30 min after cholinergic stimulation of the LHA.
projections to the locus coeruleus (LC) which activate the noradrenergic neurons located there. These send From all of these results, it is clear that the natriuresis induced by intrahypothalamic injection of carbaaxons to the AV3V and stimulate cholinergic interneurons which activate the ANPergic neurons. These neuchol occurs completely independently of the alterations in renal efferent nerve activity induced by rons stimulate the release of OT from the neurohypophysis. The released OT circulates to the atria and intrahypothalamic actions of carbachol.
triggers ANP release which then induces the natriurConclusions esis. The fact that OT antagonists block the ANP release from suckling and basal and OT-induced release of Our hypothesis is that BVE induces stretch of sinoaortic and renal baroreceptors which increases afferent ANP from atria in vitro strongly supports our hypoth- 
